Katalóg evidencie publikačnej činnosti PU


ID záznamu:214247
Kategória:ADC
Autor:Shore Neal (10%)
Autor:Minčík Ivan (10%)
Autor:DeGuenther Mark (8%)
Autor:Student Vladimir jr. (8%)
Autor:Jievaltas Mindaugas (8%)
Autor:Patočková Jitka (8%)
Autor:Simpson Kelle (8%)
Autor:Huang Shih-Tsung (8%)
Autor:Li Yuhua (8%)
Autor:Lee Yisheng (8%)
Autor:Chien Ben (8%)
Autor:Mao John (8%)
Názov:A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients [print, elektronický dokument]
Zdroj:World Journal of Urology [print]
Lokácia:Roč. 38, č. 1. - Berlín, (2020), s. 111-119
ISSN:0724-4983. - ISSN 1433-8726
URL:https://link.springer.com/journal/345/volumes-and-issues/38-1
Ohlas:[1] 2021. ZHOU, H., XIE, J., ZHU, X. Pharmacokinetic and pharmacodynamic evaluation of the new prolonged-release leuprorelin acetate microspheres for injection compared with Enantone in healthy Chinese male volunteers. In Expert opinion on drug metabolism and toxicology, ISSN 1742-5255. 2021, vol. 17, no. 9, s. 1149-1156. WOS:000683613000001;SCOPUS.
Oblasť výskumu:180